Search Results - "Pana, Zoi D"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Fungal diversity in the soil Mycobiome: Implications for ONE health by Yiallouris, Andreas, Pana, Zoi D., Marangos, Giorgos, Tzyrka, Ioanna, Karanasios, Spyridon, Georgiou, Iliana, Kontopyrgia, Kyriaki, Triantafyllou, Eleni, Seidel, Danila, Cornely, Oliver A., Johnson, Elizabeth O., Panagiotou, Stavros, Filippou, Charalampos

    Published in One health (01-06-2024)
    “…Today, over 300 million individuals worldwide are afflicted by severe fungal infections, many of whom will perish. Fungi, as a result of their plastic genomes…”
    Get full text
    Journal Article
  2. 2

    Is Piperacillin-Tazobactam Effective for the Treatment of Pyelonephritis Caused by Extended-Spectrum β-Lactamase–Producing Organisms? by Sharara, Sima L, Amoah, Joe, Pana, Zoi D, Simner, Patricia J, Cosgrove, Sara E, Tamma, Pranita D

    Published in Clinical infectious diseases (05-11-2020)
    “…Abstract Background Limited data exist regarding the efficacy of piperacillin-tazobactam (TZP) for the management of nonbacteremic pyelonephritis caused by…”
    Get full text
    Journal Article
  3. 3

    Innovative approaches for vaccine trials as a key component of pandemic preparedness - a white paper by Bethe, Ullrich, Pana, Zoi D, Drosten, Christian, Goossens, Herman, König, Franz, Marchant, Arnaud, Molenberghs, Geert, Posch, Martin, Van Damme, Pierre, Cornely, Oliver A

    Published in Infection (17-07-2024)
    “…WHO postulates the application of adaptive design features in the global clinical trial ecosystem. However, the adaptive platform trial (APT) methodology has…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium by Cornely, Oliver A, Alastruey-Izquierdo, Ana, Arenz, Dorothee, Chen, Sharon C A, Dannaoui, Eric, Hochhegger, Bruno, Hoenigl, Martin, Jensen, Henrik E, Lagrou, Katrien, Lewis, Russell E, Mellinghoff, Sibylle C, Mer, Mervyn, Pana, Zoi D, Seidel, Danila, Sheppard, Donald C, Wahba, Roger, Akova, Murat, Alanio, Alexandre, Al-Hatmi, Abdullah M S, Arikan-Akdagli, Sevtap, Badali, Hamid, Ben-Ami, Ronen, Bonifaz, Alexandro, Bretagne, Stéphane, Castagnola, Elio, Chayakulkeeree, Methee, Colombo, Arnaldo L, Corzo-León, Dora E, Drgona, Lubos, Groll, Andreas H, Guinea, Jesus, Heussel, Claus-Peter, Ibrahim, Ashraf S, Kanj, Souha S, Klimko, Nikolay, Lackner, Michaela, Lamoth, Frederic, Lanternier, Fanny, Lass-Floerl, Cornelia, Lee, Dong-Gun, Lehrnbecher, Thomas, Lmimouni, Badre E, Mares, Mihai, Maschmeyer, Georg, Meis, Jacques F, Meletiadis, Joseph, Morrissey, C Orla, Nucci, Marcio, Oladele, Rita, Pagano, Livio, Pasqualotto, Alessandro, Patel, Atul, Racil, Zdenek, Richardson, Malcolm, Roilides, Emmanuel, Ruhnke, Markus, Seyedmousavi, Seyedmojtaba, Sidharthan, Neeraj, Singh, Nina, Sinko, János, Skiada, Anna, Slavin, Monica, Soman, Rajeev, Spellberg, Brad, Steinbach, William, Tan, Ban Hock, Ullmann, Andrew J, Vehreschild, Jörg J, Vehreschild, Maria J G T, Walsh, Thomas J, White, P Lewis, Wiederhold, Nathan P, Zaoutis, Theoklis, Chakrabarti, Arunaloke

    Published in The Lancet infectious diseases (01-12-2019)
    “…Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality. Diagnosis is often delayed, and disease tends to progress rapidly…”
    Get full text
    Journal Article
  6. 6

    Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States by Tamma, Pranita D, Sharara, Sima L, Pana, Zoi D, Amoah, Joe, Fisher, Stephanie L, Tekle, Tsigereda, Doi, Yohei, Simner, Patricia J

    Published in Open forum infectious diseases (11-08-2019)
    “…Knowledge of whether Enterobacterales are not susceptible to ceftriaxone without understanding the underlying resistance mechanisms may not be sufficient to…”
    Get full text
    Journal Article